<DOC>
	<DOCNO>NCT03090841</DOCNO>
	<brief_summary>The purpose study determine 1 ) diagnosis CMV fetal infection could do directly maternal blood instead request amniocentesis 2 ) innovative technology proteomic , transcriptomic , methylomic lipidomic apply fetal sample could allow discovery new biomarkers fetal infection .</brief_summary>
	<brief_title>Biomarkers Cytomegalovirus Fetal Infection Disease</brief_title>
	<detailed_description>Human cytomegalovirus ( HCMV ) common cause congenital infection worldwide . The diagnosis CMV fetal infection relies detection viral DNA amniotic fluid polymerase chain reaction amniocentesis . Non-invasive diagnosis fetal infection directly maternal blood available . Symptoms develop 10 % HCMV-infected fetus . Despite important advance medical imaging , establish prognosis infect fetus remain challenge . Thrombocytopenia , blood HCMV DNA , anti-HCMV immunoglobulin M β2-microglobulin recognize biomarkers symptomatic fetal infection . However , predictive value individual marker . Omics technology could help establish multimarker signature symptomatic infection . The objective study : - validate fetal blood HCMV DNA , anti-HCMV immunoglobulin M , β2-microglobulin platelet count biomarkers fetal disease ; - identify new biomarkers severe fetal disease use transcriptomic , methylomic lipidomic analysis fetal blood amniotic fluid . - validate non-invasive CMV fetal infection diagnosis tool base deep-sequencing target CMV gene maternal blood</detailed_description>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<criteria>CMV case : Informed consent obtain mother ; Pregnant woman either history primary CMV infection pregnancy carry fetus ultrasound feature compatible CMV infection willing amniocentesis fetal diagnosis CMV infection Control case : Pregnant woman carry fetus aneuploidydysgonosomy CMV case : Fetuses older 26 week gestation time diagnosis HCMV infection impossibility collect foetal sample end 26th week gestation Mother unable understand protocol Absence inform consent Any clinical rationale perform cordocentesis Mother &lt; 18 year age Administration immunoglobulins antiviral therapy mother collection fetal sample diagnosis symptomatic fetal infection Administration antiHCMV drug foetus collection fetal sample diagnosis symptomatic fetal infection Administration immunosuppressive drug mother pregnancy Maternal auto immune disorder Multiple pregnancy . Control case : Mother unable understand protocol Absence inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cytomegalovirus Congenital</keyword>
	<keyword>Non-invasive diagnosis</keyword>
	<keyword>Omics</keyword>
	<keyword>Biomarkers</keyword>
</DOC>